Showing results (1471-1480 of 1,826) with videos related to

Sort By:
Pageof 183
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 29, 2025
Ethical considerations of prospective data collection for stereotactic arrhythmia radioablation (STAR): an overview from the STOPSTORM.eu consortiumChiara Crico, Oliver Blanck, Marcin Miszczyk, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2013
Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosisNico Lachmann, Christine Happle, Mania Ackermann, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 11, 2023
Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the Swiss cohortClaudia Herrera Siklody, Luis Schiappacasse, Raphaël Jumeau, et al.
Bone Marrow Transplantation|July 8, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMTRyszard Swoboda, Myriam Labopin, Nicolaus Kröger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working PartyMarie Robin, Annalisa Ruggeri, Myriam Labopin, et al.
Bone Marrow Transplantation|May 2, 2022
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
American Journal of Hematology|June 10, 2024
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|June 18, 2024
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working partyHélène Schoemans, Linda J Burns, Sarah J Liptrott, et al.
ERJ Open Research|March 30, 2022
Autoimmune pulmonary alveolar proteinosis in childrenMatthias Griese, Panagiota Panagiotou, Effrosyni D Manali, et al.
Pageof 183